ABSTRACT: 2,4-Dichloro-pyrimidine-6-carbonylchloride (2) was synthesized by refluxing orotic acid (1) with phosphorus oxychloride and phosphorus pentachloride. Compound (2) underwent a smooth Friedel-Craft's reaction with a number of substituted benzene to yield 2,4-Dichloro-6-aroylpyrimidines 6 and 7 which were converted to the corresponding dimethoxy pyrimidines (8, 9) on treatment with sodium methoxide in methanol. The iodination reaction on 2,4-dimethoxy-6-aroylpyrimidines (8, 9) was attempted by several methods but only NIS-TFA-TFAA method gave the desired products, 2,4-dimethoxy-5-iodo-6-aroylpyrimidine (10, 11) in good yields.
INTRODUCTION
Idoxuridine (IDU) I and Trifluorothymidine (TFT) II were the first pyrimidine nucleoside 1 analogues ever shown to be effective against herpesviruses in particular HSV-1. They were also the first to be approved for clinical use, and are, as of today, still used as eye drops in the topical treatment of HSV-1 keratitis. However, neither IDU nor TFT can be used systematically because they are too toxic, especially to the bone marrow. The importance of 5-substituted derivatives of uracil as anticancer and antiviral (including anti-AIDS) agents is wellestablished. For example, 5-fluorouracil (5-FU) III and the corresponding 2-deoxyribonucleoside (FUdR) 2 have been of importance in cancer chemotherapy for decades.
Dihydroalkoxybenzyloxopyrimidines (DABOs) are a new class of specific inhibitors of human immunodeficiency virus type 1 (HIV-1) which possess a benzyl moiety and an alkyl (cycloalkyl) chain linked through an oxygen bridge to the uracil or thymine base. [3] [4] [5] Various thio analogues 6 of dihydroalkoxybenzyloxopyrimidines (DABOs), a new class of non-nucleoside reverse transcriptase inhibitors, were found to be selectively inhibit the HIV-1 multiplication in vitro. The antiviral activities of a series of 6-arylmethyl-1-allyloxymethyl)-5-alkyluracil derivatives were found. 10 Iodo derivatives of pyrimidines and uracils have been utilized for the synthesis of corresponding carbon substituted derivatives. 11 Thus, the availability of suitable iodo derivatives of pyrimidines and uracils become important. Recently, we have reported a synthesis of 4-acyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidines (6-acyluracils and 4-acyl-6-aryl-2-oxo-2, 3-dihydropyrimidines. 12 In connection to our studies on orotic acid, we needed a large quantity of 5-iodo-2,4-dimethoxypyrimidine.
MATERIALS AND METHODS
Melting points were determined in open capillary tubes on Gallenkamp (England) melting point apparatus and were uncorrected. IR spectra were recorded on a Shimadzu FTIR spectrophotometer and UV spectra were recorded in dry EtOH with a Shimadzu visible spectrometer.
1 H NMR and 13 C NMR spectra were recorded on a Bruker DPX -400 spectrometer (400-MHz) using TMS as internal reference. Analytical thin-layer chromatography (TLC) was performed on precoated silica gel 60 F 254 (E. Merck), and the spots were visualized with UV light. Column chromatography was performed on silica gel (60-120 mesh). Elemental analyses (C, H, N) were carried out on a Perkin-Elmer 240 C analyser. Orotic acid, POCl 3 , primary arylamine, NIS, TFA, TFAA and other reagents were purchased from E. Merck (Germany) and Fluka (Switzerland).
Preparation of 2,4-Dichloropyrimidine-6-carbonyl chloride (2), A mixture of 2,4-dioxo-1,3,5-trihydropyrimidine-6-carboxylic acid (orotic acid) 5.0 g (0.032 mol) and phosphorus oxychloride (POCl 3, 40 ml) was refluxed for 24 hours at 105-108 o C, then phosphorus pentachloride (15 g, 0.072 mol) was added into the reaction mixture. 13 The mixture was then refluxed for 24 hours. Phosphorus oxychloride was recovered under reduced pressure. The residue was distilled under reduced pressure and 2, 4-dichloropyrimidine-6-carbonyl chloride (2), (4.0 g) was obtained as dense colorless liquid. Synthesis of 2,4-dichloro-6-aroylpyrimidines (6, 7) . To the substituted benzenes 4, 5 (60 ml) anhydrous aluminium chloride (6 g) was added at 0 o C. To the cold solution 2, 4-dichloropyrimidine-6-carbonyl chloride (2) (6 g) was added slowly. The mixture was allowed to warm up to room temperature and stirred for 5-6 hours and poured into cold hydrochloric acid solution (2 ml, 12 M HCl in 60 ml water). The mixture was extracted with chloroform (3 x 25 ml). The combined organic layer was washed with sodium bicarbonate, distilled water and dried over anhydrous sodium sulfate. After removal of solvent, the product was purified by column chromatography over silica gel and then it was crystallized to afford the desired products 6 and 7 in good yield. Preparation of 2,4-dimethoxy-6-methyl orotate (3). 2,4-Dichloro pyrimidine-6-carboxyl chloride 2 ( 1m mol) in dry methanol (50 ml) was added drop wise to an ice-cold solution of sodium (1.95g, 0.084 mol) in dry methanol (50 ml. The whole solution was stirred at room temperature for 4 hours. After removal of solvent a solid mass was obtained. To this solid mass 100 mL water was added and neutralized by dilute hydrochloric acid. Then it was extracted with chloroform (50 mL × 3). The organic layer was then washed with water, 10% NaHCO 3 and dried over anhyd. Na 2 
2,4-Dichloro-6-p-bromobenzoylpyrimidine (6).

Synthesis of 2, 4-dimethoxy-5-iodo-6-aroyl pyrimidines (10, 11).
A mixture of 2, 4-dimethoxy-6-p-aroylpyrimidine (500 mg, 1.6954 mmol) trifluoroacetic acid (50 ml and trifluoroacetic anhydride (1 ml was refluxed for 20 minutes. NIodosuccinimide (1.2 equiv, 457.74 mg) was added and the reaction mixture was further refluxed for 8 hours. The reaction mixture was allowed to cool to room temperature and the solvent was removed under reduced pressure. The residue was dissolved in chloroform (300 ml, and successively washed with water (50 ml), saturated sodium bicarbonate (2×40 ml, saturated sodium thiosulfates (2 × 40 ml and water (2 × 40 ml. The chloroform layer was dried over anhyd. Sodium sulfate and concentrated to dryness to give 1.15g crude mass. The crude mass was crystallized from methanol. 
2,4-Dimethoxy-5-iodo-6-p-bromobenzoyl pyrimidine (10
RESULTS AND DISCUSSION
2,4-Dichloropyrimidine-6-carbonyl chloride (2) was synthesized according to the procedure of Gershon 13 by heating orotic acid (1) with phosphorus oxychloride and phosphorus pentachloride as shown in the scheme 1.
Compound 2 underwent a smooth Friedel-Crafts reaction with a number of substituted benzene derivatives in the presence of anhydrous aluminium chloride in which the acid chloride moiety was found to react predominantly as shown in the scheme 2. 
Scheme 2
The yields of the Friedel-Craft's products were good (70-87%). The Friedel-Crafts reaction took place at the p-position of the substituent on the benzene ring The Friedel-Crafts reaction of 2,4-dichloropyrimidine-6-carbonylchloride (2) and benzene derivatives with electron with drawing substituents on the benzene ring, e.g. benzophenon, p-nitrotoluene and 2-methyl benzaldehyde, however failed. Similarly, phenyl acetylene and styrene failed to give desired products.
6-Aroyl-2,4-dichloropyrimidines (6,7) were converted to the corresponding 2, 4-dimethoxy pyrimidines (8, 9) on treatment with sodium methoxide in methanol as shown in the scheme 3.
2,4-Dichloropyrimidine-6-carbonyl chloride was also converted to 2,4-dimethoxypyrimidine-6-methylorotate (3) by refluxing with sodium methoxide in methanol for 4 hrs.
In view of the extensive use of iodo derivatives of pyrimidine for the synthesis of the corresponding carbon-substituted derivatives, we attempted to synthesis 5-iodopyrimidines by using different methods. The iodination reaction was attempted by several methods, such as, I 2 in alkali solution, ICl in methanol, I 2 in CHCl 3 in presence of nitric acid, and NaI in DMF but only NIS-TFA-TFAA method gave the desired products. The iodination reaction of 2, 4-dichloro-6-aroyl pyrimidine was carried out by using NIS-TFA-TFAA under refluxing condition but desired compound 5-iodo pyrimidine was not obtained.
When 2, 4-dimethoxy-6-aroyl pyrimidines (8, 9) were subjected to iodination reaction utilizing NIS-TFA-TFAA under refluxing condition as shown in the scheme 4, the desired product 2, 4-dimethoxy-5-iodo-6-aroylpyrimidines (10, 11) were obtained in good yield.
2,4-Dimethoxy-6-methyl orotate (3) was also subjected to iodination reaction using NIS-TFA-TFAA under the same condition to afford 2, 4-dimethooxy-5-iodo 6-methyl orotate (12) as shown in the scheme 5. 
Scheme 5
N-Iodosuccinimide in trifluoroacetic acid and trifluoroacetic anhydride was found to be an excellent reagent for the iodonation at C-5 position of 2, 4-dimethoxy-6-substituted pyrimidine.
CONCLUSION
Here, we have demonstrated a convenient and facile method for the synthesis of 2, 4-dichloro-6-paroyl-pyrimidine and 2, 4-dicholoro-6-methyl orotate and their corresponding 2, 4-dimethoxy pyrimidine. Iodination at C-5 position also described here. Niodosuccinimide in trifluoroacetic acid and trifluoroacetic anhydride was found to be excellent reagents for the iodination at C-5 position of 2, 4-dimethoxy-6-aroyl pyrimidine and 2, 4-dimethoxy-6-methyl orotate. The most important features of the synthesis are that readily available starting materials are used under relatively mild reaction conditions. Also, no toxic and hazardous compounds are produced by these syntheses. A variety of functional groups can be introduced at the C-5 and C-6 position of the pyrimidine ring by this procedure. Through this methodology biologically important uracil and pyrimidine derivatives can be easily synthesized. 2, 4-Dimethoxy-5-iodo-6-aroyl pyrimidine might be used as an intermediate for the synthesis of biologically important compounds. This method will be attractive to both organic and medicinal chemists.
